BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18381934)

  • 1. Dissection of the APCCdh1-Skp2 cascade in breast cancer.
    Fujita T; Liu W; Doihara H; Date H; Wan Y
    Clin Cancer Res; 2008 Apr; 14(7):1966-75. PubMed ID: 18381934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Skp2-p27 axis by the Cdh1/anaphase-promoting complex pathway in colorectal tumorigenesis.
    Fujita T; Liu W; Doihara H; Wan Y
    Am J Pathol; 2008 Jul; 173(1):217-28. PubMed ID: 18535175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vivo study of Cdh1/APC in breast cancer formation.
    Fujita T; Liu W; Doihara H; Wan Y
    Int J Cancer; 2009 Aug; 125(4):826-36. PubMed ID: 19350629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition.
    Liu W; Wu G; Li W; Lobur D; Wan Y
    Mol Cell Biol; 2007 Apr; 27(8):2967-79. PubMed ID: 17283060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex.
    Wei W; Ayad NG; Wan Y; Zhang GJ; Kirschner MW; Kaelin WG
    Nature; 2004 Mar; 428(6979):194-8. PubMed ID: 15014503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.
    Pavlides SC; Lecanda J; Daubriac J; Pandya UM; Gama P; Blank S; Mittal K; Shukla P; Gold LI
    Cell Cycle; 2016; 15(7):931-47. PubMed ID: 26963853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
    Lwin T; Hazlehurst LA; Dessureault S; Lai R; Bai W; Sotomayor E; Moscinski LC; Dalton WS; Tao J
    Blood; 2007 Sep; 110(5):1631-8. PubMed ID: 17502456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from degradation by APC(Cdh1) in G1 phase.
    Rodier G; Coulombe P; Tanguay PL; Boutonnet C; Meloche S
    EMBO J; 2008 Feb; 27(4):679-91. PubMed ID: 18239684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid downregulates Rae1 leading to APC(Cdh1) activation and neuroblastoma SH-SY5Y differentiation.
    Cuende J; Moreno S; Bolaños JP; Almeida A
    Oncogene; 2008 May; 27(23):3339-44. PubMed ID: 18212744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear translocation of Skp2 facilitates its destruction in response to TGFβ signaling.
    Hu D; Liu W; Wu G; Wan Y
    Cell Cycle; 2011 Jan; 10(2):285-92. PubMed ID: 21212736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Don't skip the G1 phase: how APC/CCdh1 keeps SCFSKP2 in check.
    Bashir T; Pagano M
    Cell Cycle; 2004 Jul; 3(7):850-2. PubMed ID: 15190201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCF
    Li F; Mladenov E; Mortoga S; Iliakis G
    Cell Death Dis; 2020 Jul; 11(7):548. PubMed ID: 32683422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of APC/C (Cdh1) ubiquitin ligase in differentiation of human embryonic stem cells.
    Bar-On O; Shapira M; Skorecki K; Hershko A; Hershko DD
    Cell Cycle; 2010 May; 9(10):1986-9. PubMed ID: 20473026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors.
    Lehman NL; Tibshirani R; Hsu JY; Natkunam Y; Harris BT; West RB; Masek MA; Montgomery K; van de Rijn M; Jackson PK
    Am J Pathol; 2007 May; 170(5):1793-805. PubMed ID: 17456782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction.
    Gao D; Inuzuka H; Tseng A; Chin RY; Toker A; Wei W
    Nat Cell Biol; 2009 Apr; 11(4):397-408. PubMed ID: 19270695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells.
    Chen CF; Dou XW; Liang YK; Lin HY; Bai JW; Zhang XX; Wei XL; Li YC; Zhang GJ
    Cell Cycle; 2016; 15(3):432-40. PubMed ID: 26694515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering the role of APC-Cdh1 in generating the dynamics of S-phase onset.
    Yuan X; Srividhya J; De Luca T; Lee JH; Pomerening JR
    Mol Biol Cell; 2014 Feb; 25(4):441-56. PubMed ID: 24356446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of skp2 expression in primary breast cancer.
    Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
    Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.